Alzheimer's disease: A matter of blood-brain barrier dysfunction?

Journal of Experimental Medicine

Volumn 214, Issue 11, 2017, Pages 3151-3169

  Montagne, Axel ^a   Zhao, Zhen ^a   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PRESENILIN 1; TAU PROTEIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; GENETIC RISK; HUMAN; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MUTATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; HUMANS; MICE, TRANSGENIC; MUTATION; PRESENILIN-1; TAU PROTEINS;

EID: 85033373065     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20171406     Document Type: Review

References (195)

1. Akawi, N.A., F.E. Canpolat, S.M. White, J. Quilis-Esquerra, M. Morales Sanchez, M.J. Gamundi, G.H. Mochida, C.A. Walsh, B.R. Ali, and L. Al-Gazali. 2013. Delineation of the clinical, molecular and cellular aspects of novel JAM3 mutations underlying the autosomal recessive hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Hum. Mutat. 34:498-505. https ://doi.org /10.1002 /humu.22263
2. Alata, W., Y. Ye, I. St-Amour, M. Vandal, and F. Calon. 2015. Human apolipoprotein E ε4 expression impairs cerebral vascularization and blood-brain barrier function in mice. J. Cereb. Blood Flow Metab. 35:86-94. https ://doi.org /10.1038 /jcbfm.2014.172
3. Andreone, B.J., B.W. Chow, A. Tata, B. Lacoste, A. Ben-Zvi, K. Bullock, A.A. Deik, D.D. Ginty, C.B. Clish, and C. Gu. 2017. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 94:581-594. https ://doi.org /10.1016 /j.neuron.2017.03.043
4. Armstrong, R.A. 2008. Spatial correlations between beta-amyloid (Abeta) deposits and blood vessels in familial Alzheimer's disease. Folia Neuropathol. 46:241-248
5. Armulik, A., G. Genové, M. Mäe, M.H. Nisancioglu, E. Wallgard, C. Niaudet, L. He, J. Norlin, P. Lindblom, K. Strittmatter, et al. 2010. Pericytes regulate the blood-brain barrier. Nature. 468:557-561. https ://doi.org /10.1038 /nature09522
6. Arvanitakis, Z., A.W. Capuano, S.E. Leurgans, D.A. Bennett, and J.A. Schneider. 2016. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 15:934-943. https ://doi.org /10.1016 /S1474-4422(16)30029-1
7. Asgari, M., D. de Zélicourt, and V. Kurtcuoglu. 2016. Glymphatic solute transport does not require bulk flow. Sci. Rep. 6:38635. https ://doi.org /10.1038 /srep38635
8. Asgari, N., C.T. Berg, M.T. Mørch, R. Khorooshi, and T. Owens. 2015. Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier. Ann. Clin. Transl. Neurol. 2:857-863. https ://doi.org /10.1002 /acn3.221
9. Bakker, E.N.T.P., B.J. Bacskai, M. Arbel-Ornath, R. Aldea, B. Bedussi, A.W.J. Morris, R.O. Weller, and R.O. Carare. 2016. Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases. Cell. Mol. Neurobiol. 36:181-194. https ://doi.org /10.1007 / s10571-015-0273-8
10. Baloyannis, S.J., and I.S. Baloyannis. 2012. The vascular factor in Alzheimer's disease: a study in Golgi technique and electron microscopy. J. Neurol. Sci. 322:117-121. https ://doi.org /10.1016 /j.jns.2012.07.010
11. Bateman, R.J., C. Xiong, T.L.S. Benzinger, A.M. Fagan, A. Goate, N.C. Fox, D.S. Marcus, N.J. Cairns, X. Xie, T.M. Blazey, et al. Dominantly Inherited Alzheimer Network. 2012. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367:795-804. https ://doi.org /10.1056 /NEJMoa1202753
12. Beckmann, N., C. Gérard, D. Abramowski, C. Cannet, and M. Staufenbiel. 2011. Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy. J. Neurosci. 31:1023-1031. https ://doi.org /10.1523 /JNE URO SCI.4936-10.2011
13. Bell, R.D., R. Deane, N. Chow, X. Long, A. Sagare, I. Singh, J.W. Streb, H. Guo, A. Rubio, W. Van Nostrand, et al. 2009. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat. Cell Biol. 11:143-153. https ://doi.org /10.1038 /ncb1819
14. Bell, R.D., E.A. Winkler, A.P. Sagare, I. Singh, B. LaRue, R. Deane, and B.V. Zlokovic. 2010. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 68:409-427. https ://doi.org /10.1016 /j.neuron.2010.09.043
15. Bell, R.D., E.A. Winkler, I. Singh, A.P. Sagare, R. Deane, Z. Wu, D.M. Holtzman, C. Betsholtz, A. Armulik, J. Sallstrom, et al. 2012. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 485:512-516
16. Benzinger, T.L.S., T. Blazey, C.R. Jack Jr., R.A. Koeppe, Y. Su, C. Xiong, M.E. Raichle, A.Z. Snyder, B.M. Ances, R.J. Bateman, et al. 2013. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 110:E4502-E4509. https ://doi.org /10.1073 /pnas.1317918110
17. Ben-Zvi, A., B. Lacoste, E. Kur, B.J. Andreone, Y. Mayshar, H. Yan, and C. Gu. 2014. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 509:507-511. https ://doi.org /10.1038 /nature13324
18. Betsholtz, C. 2014. Physiology: Double function at the blood-brain barrier. Nature. 509:432-433. https ://doi.org /10.1038 /nature13339
19. Bien-Ly, N., C.A. Boswell, S. Jeet, T.G. Beach, K. Hoyte, W. Luk, V. Shihadeh, S. Ulufatu, O. Foreman, Y. Lu, et al. 2015. Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies. Neuron. 88:289-297. https ://doi.org /10.1016 /j.neuron.2015.09.036
20. Biron, K.E., D.L. Dickstein, R. Gopaul, and W.A. Jefferies. 2011. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One. 6:e23789. https ://doi.org /10.1371 /journal.pone.0023789
21. Blair, L.J., H.D. Frauen, B. Zhang, B.A. Nordhues, S. Bijan, Y.-C. Lin, F. Zamudio, L.D. Hernandez, J.J. Sabbagh, M.-L.B. Selenica, and C.A. Dickey. 2015. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol. Commun. 3:8. https ://doi.org /10.1186 /s40478-015-0186-2
22. Boekhoorn, K., D. Terwel, B. Biemans, P. Borghgraef, O. Wiegert, G.J.A. Ramakers, K. de Vos, H. Krugers, T. Tomiyama, H. Mori, et al. 2006. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J. Neurosci. 26:3514-3523. https ://doi.org /10.1523 /JNE URO SCI.5425-05.2006
23. Bradbury, M.W., H.F. Cserr, and R.J. Westrop. 1981. Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am. J. Physiol. 240:F329-F336
24. Brundel, M., S.M. Heringa, J. de Bresser, H.L. Koek, J.J.M. Zwanenburg, L. Jaap Kappelle, P.R. Luijten, and G.J. Biessels. 2012. High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease. J. Alzheimers Dis. 31:259-263
25. Cacciottolo, M., A. Christensen, A. Moser, J. Liu, C.J. Pike, C. Smith, M.J. LaDu, P.M. Sullivan, T.E. Morgan, E. Dolzhenko, et al. Alzheimer's Disease Neuroimaging Initiative. 2016. The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol. Aging. 37:47-57. https ://doi.org /10.1016 /j.neurobiolaging.2015.10.010
26. Castellano, J.M., J. Kim, F.R. Stewart, H. Jiang, R.B. DeMattos, B.W. Patterson, A.M. Fagan, J.C. Morris, K.G. Mawuenyega, C. Cruchaga, et al. 2011. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci. Transl. Med. 3:89ra57. https ://doi.org /10.1126 / scitranslmed.3002156
27. Castillo-Gomez, E., A. Kästner, J. Steiner, A. Schneider, B. Hettling, G. Poggi, K. Ostehr, M. Uhr, A.R. Asif, M. Matzke, et al. 2016. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-Daspartate receptor subunit NR1. Ann. Neurol. 79:144-151. https ://doi.org /10.1002 /ana.24545
28. Chabriat, H., A. Joutel, M. Dichgans, E. Tournier-Lasserve, and M.-G. Bousser. 2009. Cadasil. Lancet Neurol. 8:643-653. https ://doi.org /10.1016 /S1474-4422(09)70127-9
29. Chen, G., K.S. Chen, J. Knox, J. Inglis, A. Bernard, S.J. Martin, A. Justice, L. McConlogue, D. Games, S.B. Freedman, and R.G. Morris. 2000. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:975-979. https ://doi.org /10.1038 /35046031
30. Chen, Z.-L., A.S. Revenko, P. Singh, A.R. MacLeod, E.H. Norris, and S. Strickland. 2017. Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice. Blood. 129:2547-2556. https ://doi.org /10.1182 /blood-2016-11-753202
31. Cirrito, J.R., R. Deane, A.M. Fagan, M.L. Spinner, M. Parsadanian, M.B. Finn, H. Jiang, J.L. Prior, A. Sagare, K.R. Bales, et al. 2005. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J. Clin. Invest. 115:3285-3290. https ://doi.org /10.1172 /JCI25247
32. Coatti, G.C., M. Frangini, M.C. Valadares, J.P. Gomes, N.O. Lima, N. Cavaçana, A.F. Assoni, M.V. Pelatti, A. Birbrair, A.C.P. de Lima, et al. 2017. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient. Stem Cell Rev. 13:686-698. https ://doi.org /10.1007 /s12015-017-9752-2
33. Conejero-Goldberg, C., J.J. Gomar, T. Bobes-Bascaran, T.M. Hyde, J.E. Kleinman, M.M. Herman, S. Chen, P. Davies, and T.E. Goldberg. 2014. APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms. Mol. Psychiatry. 19:1243-1250. https :// doi.org /10.1038 /mp.2013.194
34. Cunnane, S., S. Nugent, M. Roy, A. Courchesne-Loyer, E. Croteau, S. Tremblay, A. Castellano, F. Pifferi, C. Bocti, N. Paquet, et al. 2011. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition. 27:3-20. https ://doi.org /10.1016 /j.nut.2010.07.021
35. Daneman, R., L. Zhou, A.A. Kebede, and B.A. Barres. 2010. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 468:562-566. https ://doi.org /10.1038 /nature09513
36. Davalos, D., J.K. Ryu, M. Merlini, K.M. Baeten, N. Le Moan, M.A. Petersen, T.J. Deerinck, D.S. Smirnoff, C. Bedard, H. Hakozaki, et al. 2012. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun. 3:1227. https ://doi.org /10.1038 /ncomms2230
37. Davis, J., F. Xu, R. Deane, G. Romanov, M.L. Previti, K. Zeigler, B.V. Zlokovic, and W.E. Van Nostrand. 2004. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J. Biol. Chem. 279:20296-20306. https ://doi.org /10.1074 /jbc.M312946200
38. Deane, R., S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, et al. 2003. RAGE mediates amyloidbeta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9:907-913. https ://doi.org /10.1038 /nm890
39. Deane, R., Z. Wu, A. Sagare, J. Davis, S. Du Yan, K. Hamm, F. Xu, M. Parisi, B. LaRue, H.W. Hu, et al. 2004. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 43:333-344. https ://doi.org /10.1016 /j.neuron.2004.07.017
40. Deane, R., A. Sagare, K. Hamm, M. Parisi, S. Lane, M.B. Finn, D.M. Holtzman, and B.V. Zlokovic. 2008. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest. 118:4002-4013. https ://doi.org /10.1172 /JCI36663
41. Deane, R., I. Singh, A.P. Sagare, R.D. Bell, N.T. Ross, B. LaRue, R. Love, S. Perry, N. Paquette, R.J. Deane, et al. 2012. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122:1377-1392. https ://doi.org /10.1172 /JCI58642
42. Deo, A.K., S. Borson, J.M. Link, K. Domino, J.F. Eary, B. Ke, T.L. Richards, D.A. Mankoff, S. Minoshima, F. O'Sullivan, et al. 2014. Activity of P-Glycoprotein, α β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease. J. Nucl. Med. 55:1106-1111. https ://doi.org /10.2967 /jnumed.113.130161
43. Dermaut, B., G. Roks, J. Theuns, R. Rademakers, J.J. Houwing-Duistermaat, S. Serneels, A. Hofman, M.M. Breteler, M. Cruts, C. Van Broeckhoven, and C.M. van Duijn. 2001. Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease. J. Neurol. 248:935-939. https ://doi.org /10.1007 /s004150170044
44. Di Cataldo, V., A. Géloën, J.-B. Langlois, F. Chauveau, B. Thézé, V. Hubert, M. Wiart, E.N. Chirico, J. Rieusset, H. Vidal, et al. 2016. Exercise Does Not Protect against Peripheral and Central Effects of a High Cholesterol Diet Given Ad libitum in Old ApoE(-/-) Mice. Front. Physiol. 7:453. https :// doi.org /10.3389 /fphys.2016.00453
45. Domnitz, S.B., E.M. Robbins, A.W. Hoang, M. Garcia-Alloza, B.T. Hyman, G.W. Rebeck, S.M. Greenberg, B.J. Bacskai, and M.P. Frosch. 2005. Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J. Neuropathol. Exp. Neurol. 64:588-594. https ://doi.org /10.1097 /01.jnen.0000171644.00180.fc
46. Duff, K., C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Perez-tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, et al. 1996. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:710-713. https ://doi.org /10.1038 /383710a0
47. Elbert, D.L., B.W. Patterson, and R.J. Bateman. 2015. Analysis of a compartmental model of amyloid beta production, irreversible loss and exchange in humans. Math. Biosci. 261:48-61. https ://doi.org /10.1016 /j.mbs.2014.11.004
48. Engelhardt, B., P. Vajkoczy, and R.O. Weller. 2017. The movers and shapers in immune privilege of the CNS. Nat. Immunol. 18:123-131. https ://doi.org /10.1038 /ni.3666
49. Faraco, G., L. Park, P. Zhou, W. Luo, S.M. Paul, J. Anrather, and C. Iadecola. 2016. Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP. J. Cereb. Blood Flow Metab. 36:241-252. https ://doi.org /10.1038 / jcbfm.2015.79
50. Farkas, E., and P.G. Luiten. 2001. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64:575-611. https ://doi.org /10.1016 /S0301-0082(00)00068-X
51. Fleisher, A.S., K. Chen, Y.T. Quiroz, L.J. Jakimovich, M. Gutierrez Gomez, C.M. Langois, J.B.S. Langbaum, A. Roontiva, P. Thiyyagura, W. Lee, et al. 2015. Associations between biomarkers and age in the presenilin 1. E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study. JAMA Neurol. 72:316-324. https ://doi.org /10.1001 /jamaneurol.2014.3314
52. Fullerton, S.M., G.A. Shirman, W.J. Strittmatter, and W.D. Matthew. 2001. Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice. Exp. Neurol. 169:13-22. https ://doi.org /10.1006 /exnr.2001.7631
53. Gama Sosa, M.A., R.D. Gasperi, A.B. Rocher, A.C.-J. Wang, W.G.M. Janssen, T. Flores, G.M. Perez, J. Schmeidler, D.L. Dickstein, P.R. Hof, and G.A. Elder. 2010. Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. Am. J. Pathol. 176:353-368. https ://doi.org /10.2353 /ajpath.2010.090482
54. Garbuzova-Davis, S., E. Haller, S. Saporta, I. Kolomey, S.V. Nicosia, and P.R. Sanberg. 2007a. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 1157:126-137. https ://doi.org /10.1016 /j.brainres.2007.04.044
55. Garbuzova-Davis, S., S. Saporta, E. Haller, I. Kolomey, S.P. Bennett, H. Potter, and P.R. Sanberg. 2007b. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One. 2:e1205. https ://doi.org /10.1371 /journal.pone.0001205
56. Gerwien, H., S. Hermann, X. Zhang, E. Korpos, J. Song, K. Kopka, A. Faust, C. Wenning, C.C. Gross, L. Honold, et al. 2016. Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier. Sci. Transl. Med. 8:364ra152. https ://doi.org /10.1126 /scitranslmed.aaf8020
57. Ghosh, M., M. Balbi, F. Hellal, M. Dichgans, U. Lindauer, and N. Plesnila. 2015. Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Ann. Neurol. 78:887-900. https ://doi.org /10.1002 /ana.24512
58. Girouard, H., and C. Iadecola. 2006. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J. Appl. Physiol. 100:328-335. https ://doi.org /10.1152 /japplphysiol.00966.2005
59. Griffin, J.H., B.V. Zlokovic, and L.O. Mosnier. 2015. Activated protein C: biased for translation. Blood. 125:2898-2907. https ://doi.org /10.1182 / blood-2015-02-355974
60. Guemez-Gamboa, A., L.N. Nguyen, H. Yang, M.S. Zaki, M. Kara, T. Ben-Omran, N. Akizu, R.O. Rosti, B. Rosti, E. Scott, et al. 2015. Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome. Nat. Genet. 47:809-813. https ://doi.org /10.1038 /ng.3311
61. Hachinski, V. 2016. Correction. World Stroke Organization. Stroke and potentially preventable dementias proclamation: updated World Stroke Day proclamation. Stroke. 47:e37
62. Hafezi-Moghadam, A., K.L. Thomas, and D.D. Wagner. 2007. ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. Am. J. Physiol. Cell Physiol. 292:C1256-C1262. https ://doi.org /10.1152 / ajpcell.00563.2005
63. Hajjar, I., F. Sorond, and L.A. Lipsitz. 2015. Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension. J. Am. Geriatr. Soc. 63:276-281. https ://doi.org /10.1111 /jgs.13235
64. Halliday, M.R., N. Pomara, A.P. Sagare, W.J. Mack, B. Frangione, and B.V. Zlokovic. 2013. Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein ε4 carriers and blood-brain barrier breakdown. JAMA Neurol. 70:1198-1200. https ://doi.org /10.1001 /jamaneurol.2013.3841
65. Halliday, M.R., S.V. Rege, Q. Ma, Z. Zhao, C.A. Miller, E.A. Winkler, and B.V. Zlokovic. 2016. Accelerated pericyte degeneration and bloodbrain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. J. Cereb. Blood Flow Metab. 36:216-227. https ://doi.org /10.1038 /jcbfm.2015.44
66. Hammer, C., B. Stepniak, A. Schneider, S. Papiol, M. Tantra, M. Begemann, A.-L. Sirén, L.A. Pardo, S. Sperling, S. Mohd Jofrry, et al. 2014. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol. Psychiatry. 19:1143-1149. https ://doi.org /10.1038 /mp.2013.110
67. Harold, D., R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, M.L. Hamshere, J.S. Pahwa, V. Moskvina, K. Dowzell, A. Williams, et al. 2009. Genome-wide association study identifies variants at CLU and PIC ALM associated with Alzheimer's disease. Nat. Genet. 41:1088-1093. https ://doi.org /10.1038 /ng.440
68. He, L., M. Vanlandewijck, E. Raschperger, M. Andaloussi Mäe, B. Jung, T. Lebouvier, K. Ando, J. Hofmann, A. Keller, and C. Betsholtz. 2016. Analysis of the brain mural cell transcriptome. Sci. Rep. 6:35108. https :// doi.org /10.1038 /srep35108
69. Heringa, S.M., Y.D. Reijmer, A. Leemans, H.L. Koek, L.J. Kappelle, and G.J. Biessels. Utrecht Vascular Cognitive Impairment (VCI) Study Group. 2014. Multiple microbleeds are related to cerebral network disruptions in patients with early Alzheimer's disease. J. Alzheimers Dis. 38:211-221
70. Hers, H.G., and C. De Duve. 1950. [The hexosephosphatase system; partition of activity of glucose-6-phosphatase in the tissues]. Bull. Soc. Chim. Biol. (Paris). 32:20-29
71. Hladky, S.B., and M.A. Barrand. 2014. Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence. Fluids Barriers CNS. 11:26. https ://doi.org /10.1186 /2045-8118-11-26
72. Holter, K.E., B. Kehlet, A. Devor, T.J. Sejnowski, A.M. Dale, S.W. Omholt, O.P. Ottersen, E.A. Nagelhus, K.-A. Mardal, and K.H. Pettersen. 2017. Interstitial solute transport in 3D reconstructed neuropil occurs by diffusion rather than bulk flow. Proc. Natl. Acad. Sci. USA. 114:9894-9899. https ://doi.org /10.1073 /pnas.1706942114
73. Holtzman, D.M., A.M. Fagan, B. Mackey, T. Tenkova, L. Sartorius, S.M. Paul, K. Bales, K.H. Ashe, M.C. Irizarry, and B.T. Hyman. 2000. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47:739-747. https ://doi.org /10.1002 /1531-8249(200006)47 :6<739::AID-ANA6>3.0.CO;2-8
74. Holtzman, D.M., J. Herz, and G. Bu. 2012. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2:a006312. https ://doi.org /10.1101 /cshperspect.a006312
75. Hsiao, K., P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:99-102. https ://doi.org /10.1126 /science.274.5284.99
76. Huang, M.T., and R.L. Veech. 1985. Metabolic fluxes between [14C]2-deoxy-D-glucose and [14C]2-deoxy-D-glucose-6-phosphate in brain in vivo. J. Neurochem. 44:567-573. https ://doi.org /10.1111 /j.1471-4159.1985.tb05450.x
77. Huang, K.-L., E. Marcora, A.A. Pimenova, A.F. Di Narzo, M. Kapoor, S.C. Jin, O. Harari, S. Bertelsen, B.P. Fairfax, J. Czajkowski, et al. 2017. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease. Nat. Neurosci. 20:1052-1061. https ://doi.org /10.1038 /nn.4587
78. Hultman, K., S. Strickland, and E.H. Norris. 2013. The APOE ε4/ε4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients. J. Cereb. Blood Flow Metab. 33:1251-1258. https ://doi.org /10.1038 /jcbfm.2013.76
79. Iadecola, C. 2013. The pathobiology of vascular dementia. Neuron. 80:844-866. https ://doi.org /10.1016 /j.neuron.2013.10.008
80. Iadecola, C. 2017. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron. 96:17-42. https :// doi.org /10.1016 /j.neuron.2017.07.030
81. Iliff, J.J., M. Wang, Y. Liao, B.A. Plogg, W. Peng, G.A. Gundersen, H. Benveniste, G.E. Vates, R. Deane, S.A. Goldman, et al. 2012. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 4:147ra111. https ://doi.org /10.1126 /scitranslmed.3003748
82. Iturria-Medina, Y., R.C. Sotero, P.J. Toussaint, J.M. Mateos-Pérez, and A.C. Evans. Alzheimer's Disease Neuroimaging Initiative. 2016. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat. Commun. 7:11934. https ://doi.org /10.1038 /ncomms11934
83. Jackman, K., T. Kahles, D. Lane, L. Garcia-Bonilla, T. Abe, C. Capone, K. Hochrainer, H. Voss, P. Zhou, A. Ding, et al. 2013. Progranulin deficiency promotes post-ischemic blood-brain barrier disruption. J. Neurosci. 33:19579-19589. https ://doi.org /10.1523 /JNE URO SCI.4318-13.2013
84. Jessen, N.A., A.S.F. Munk, I. Lundgaard, and M. Nedergaard. 2015. The Glymphatic System: A Beginner's Guide. Neurochem. Res. 40:2583-2599. https ://doi.org /10.1007 /s11064-015-1581-6
85. Jin, B.-J., A.J. Smith, and A.S. Verkman. 2016. Spatial model of convective solute transport in brain extracellular space does not support a 'glymphatic' mechanism. J. Gen. Physiol. 148:489-501. https ://doi.org /10.1085 /jgp.201611684
86. Karch, C.M., and A.M. Goate. 2015. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry. 77:43-51. https :// doi.org /10.1016 /j.biopsych.2014.05.006
87. Karch, C.M., C. Cruchaga, and A.M. Goate. 2014. Alzheimer's disease genetics: from the bench to the clinic. Neuron. 83:11-26. https ://doi.org /10.1016 /j.neuron.2014.05.041
88. Keller, A., A. Westenberger, M.J. Sobrido, M. García-Murias, A. Domingo, R.L. Sears, R.R. Lemos, A. Ordoñez-Ugalde, G. Nicolas, J.E.G. da Cunha, et al. 2013. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat. Genet. 45:1077-1082. https :// doi.org /10.1038 /ng.2723
89. Kelly, P., P.L. McClean, M. Ackermann, M.A. Konerding, C. Hölscher, and C.A. Mitchell. 2015. Restoration of cerebral and systemic microvascular architecture in APP/PS1 transgenic mice following treatment with LiraglutideTM. Microcirc. 22:133-145. https ://doi.org /10.1111 /micc.12186
90. Kisler, K., A.R. Nelson, A. Montagne, and B.V. Zlokovic. 2017a. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 18:419-434. https ://doi.org /10.1038 /nrn.2017.48
91. Kisler, K., A.R. Nelson, S.V. Rege, A. Ramanathan, Y. Wang, A. Ahuja, D. Lazic, P.S. Tsai, Z. Zhao, Y. Zhou, et al. 2017b. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat. Neurosci. 20:406-416. https ://doi.org /10.1038 /nn.4489
92. Klohs, J., A. Deistung, F. Schweser, J. Grandjean, M. Dominietto, C. Waschkies, R.M. Nitsch, I. Knuesel, J.R. Reichenbach, and M. Rudin. 2011. Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J. Cereb. Blood Flow Metab. 31:2282-2292. https ://doi.org /10.1038 /jcbfm.2011.118
93. Klohs, J., C. Baltes, F. Princz-Kranz, D. Ratering, R.M. Nitsch, I. Knuesel, and M. Rudin. 2012. Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice. J. Neurosci. 32:1705-1713. https ://doi.org /10.1523 /JNE URO SCI.5626-11.2012
94. Klohs, J., I.W. Politano, A. Deistung, J. Grandjean, A. Drewek, M. Dominietto, R. Keist, F. Schweser, J.R. Reichenbach, R.M. Nitsch, et al. 2013. Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging. PLoS One. 8:e66097. https ://doi.org /10.1371 /journal.pone.0066097
95. Kook, S.-Y., H.S. Hong, M. Moon, C.M. Ha, S. Chang, and I. Mook-Jung. 2012. Aβ1-42-RAGE interaction disrupts tight junctions of the bloodbrain barrier via Ca2+-calcineurin signaling. J. Neurosci. 32:8845-8854. https ://doi.org /10.1523 /JNE URO SCI.6102-11.2012
96. Kruyer, A., N. Soplop, S. Strickland, and E.H. Norris. 2015. Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease. Hypertension. 66:175-182. https ://doi.org /10.1161 /HYP ERT ENS ION AHA.115.05524
97. Kumar-Singh, S., D. Pirici, E. McGowan, S. Serneels, C. Ceuterick, J. Hardy, K. Duff, D. Dickson, and C. Van Broeckhoven. 2005. Dense-core plaques in Tg2576 and PSA PP mouse models of Alzheimer's disease are centered on vessel walls. Am. J. Pathol. 167:527-543. https ://doi.org /10.1016 / S0002-9440(10)62995-1
98. Lambert, J.-C., S. Heath, G. Even, D. Campion, K. Sleegers, M. Hiltunen, O. Combarros, D. Zelenika, M.J. Bullido, B. Tavernier, et al. European Alzheimer's Disease Initiative Investigators. 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41:1094-1099. https ://doi.org /10.1038 /ng.439
99. Lane-Donovan, C., W.M. Wong, M.S. Durakoglugil, C.R. Wasser, S. Jiang, X. Xian, and J. Herz. 2016. Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice. J. Neurosci. 36:10141-10150. https ://doi.org /10.1523 /JNE URO SCI.1054-16.2016
100. Lee, J.-H., W.H. Yu, A. Kumar, S. Lee, P.S. Mohan, C.M. Peterhoff, D.M. Wolfe, M. Martinez-Vicente, A.C. Massey, G. Sovak, et al. 2010. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 141:1146-1158. https ://doi.org /10.1016 /j.cell.2010.05.008
101. Lewis, J., E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, et al. 2000. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25:402-405. https ://doi.org /10.1038 /78078
102. Liao, F., H. Yoon, and J. Kim. 2017. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease. Curr. Opin. Lipidol. 28:60-67
103. Liu, D.S., X.D. Pan, J. Zhang, H. Shen, N.C. Collins, A.M. Cole, K.P. Koster, M. Ben Aissa, X.M. Dai, M. Zhou, et al. 2015. APOE4 enhances agedependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Mol. Neurodegener. 10:7. https ://doi.org /10.1186 /s13024-015-0002-2
104. Louveau, A., I. Smirnov, T.J. Keyes, J.D. Eccles, S.J. Rouhani, J.D. Peske, N.C. Derecki, D. Castle, J.W. Mandell, K.S. Lee, et al. 2015. Structural and functional features of central nervous system lymphatic vessels. Nature. 523:337-341. https ://doi.org /10.1038 /nature14432
105. Lu, C., S. Pelech, H. Zhang, J. Bond, K. Spach, R. Noubade, E.P. Blankenhorn, and C. Teuscher. 2008. Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J. Neurosci. Res. 86:2624-2640. https :// doi.org /10.1002 /jnr.21716
106. Mahley, R.W., and Y. Huang. 2012. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron. 76:871-885. https ://doi.org /10.1016 /j.neuron.2012.11.020
107. Mann, D.M., S.M. Pickering-Brown, A. Takeuchi, and T. Iwatsubo. Members of the Familial Alzheimer's Disease Pathology Study Group. 2001. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am. J. Pathol. 158:2165-2175. https ://doi.org /10.1016 /S0002-9440(10)64688-3
108. McDougal, D.B. Jr., J.A. Ferrendelli, V. Yip, M.E. Pusateri, J.G. Carter, M.M. Chi, B. Norris, J. Manchester, and O.H. Lowry. 1990. Use of nonradioactive 2-deoxyglucose to study compartmentation of brain glucose metabolism and rapid regional changes in rate. Proc. Natl. Acad. Sci. USA. 87:1357-1361. https ://doi.org /10.1073 /pnas.87.4.1357
109. McManus, R.M., O.M. Finucane, M.M. Wilk, K.H.G. Mills, and M.A. Lynch. 2017. FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation. J. Neuroimmune Pharmacol. https ://doi.org /10.1007 /s11481-017-9753-6
110. Methia, N., P. André, A. Hafezi-Moghadam, M. Economopoulos, K.L. Thomas, and D.D. Wagner. 2001. ApoE deficiency compromises the blood brain barrier especially after injury. Mol. Med. 7:810-815
111. Milhorat, T.H. 1975. The third circulation revisited. J. Neurosurg. 42:628-645. https ://doi.org /10.3171 /jns.1975.42.6.0628
112. Miyazaki, K., Y. Ohta, M. Nagai, N. Morimoto, T. Kurata, Y. Takehisa, Y. Ikeda, T. Matsuura, and K. Abe. 2011. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J. Neurosci. Res. 89:718-728. https ://doi.org /10.1002 /jnr.22594
113. Mokgokong, R., S. Wang, C.J. Taylor, M.A. Barrand, and S.B. Hladky. 2014. Ion transporters in brain endothelial cells that contribute to formation of brain interstitial fluid. Pflugers Arch. 466:887-901. https ://doi.org /10.1007 /s00424-013-1342-9
114. Montagne, A., S.R. Barnes, M.D. Sweeney, M.R. Halliday, A.P. Sagare, Z. Zhao, A.W. Toga, R.E. Jacobs, C.Y. Liu, L. Amezcua, et al. 2015. Bloodbrain barrier breakdown in the aging human hippocampus. Neuron. 85:296-302. https ://doi.org /10.1016 /j.neuron.2014.12.032
115. Montagne, A., D.A. Nation, J. Pa, M.D. Sweeney, A.W. Toga, and B.V. Zlokovic. 2016. Brain imaging of neurovascular dysfunction in Alzheimer's disease. Acta Neuropathol. 131:687-707. https ://doi.org /10.1007 /s00401-016-1570-0
116. Montine, T.J., W.J. Koroshetz, D. Babcock, D.W. Dickson, W.R. Galpern, M.M. Glymour, S.M. Greenberg, M.L. Hutton, D.S. Knopman, A.N. Kuzmichev, et al. ADRD 2013 Conference Organizing Committee. 2014. Recommendations of the Alzheimer's disease-related dementias conference. Neurology. 83:851-860. https ://doi.org /10.1212 /WNL.0000000000000733
117. Mulder, M., A. Blokland, D.J. van den Berg, H. Schulten, A.H. Bakker, D. Terwel, W. Honig, E.R. de Kloet, L.M. Havekes, H.W. Steinbusch, and E.C. de Lange. 2001. Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab. Invest. 81:953-960. https ://doi.org /10.1038 / labinvest.3780307
118. Nelson, A.R., M.D. Sweeney, A.P. Sagare, and B.V. Zlokovic. 2016. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Biochim. Biophys. Acta. 1862:887-900. https ://doi.org /10.1016 /j.bbadis.2015.12.016
119. Nguyen, L.N., D. Ma, G. Shui, P. Wong, A. Cazenave-Gassiot, X. Zhang, M.R. Wenk, E.L.K. Goh, and D.L. Silver. 2014. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 509:503-506. https ://doi.org /10.1038 /nature13241
120. Nicaise, C., D. Mitrecic, P. Demetter, R. De Decker, M. Authelet, A. Boom, and R. Pochet. 2009. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 1301:152-162. https ://doi.org /10.1016 /j.brainres.2009.09.018
121. Nicolas, G., C. Pottier, D. Maltête, S. Coutant, A. Rovelet-Lecrux, S. Legallic, S. Rousseau, Y. Vaschalde, L. Guyant-Maréchal, J. Augustin, et al. 2013. Mutation of the PDG FRB gene as a cause of idiopathic basal ganglia calcification. Neurology. 80:181-187. https ://doi.org /10.1212 /WNL.0b013e31827ccf34
122. Nikolakopoulou, A.M., Z. Zhao, A. Montagne, and B.V. Zlokovic. 2017. Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling. PLoS One. 12:e0176225. https ://doi.org /10.1371 /journal.pone.0176225
123. Nishitsuji, K., T. Hosono, T. Nakamura, G. Bu, and M. Michikawa. 2011. Apolipoprotein E regulates the integrity of tight junctions in an isoformdependent manner in an in vitro blood-brain barrier model. J. Biol. Chem. 286:17536-17542. https ://doi.org /10.1074 /jbc.M111.225532
124. Niwa, K., K. Kazama, L. Younkin, S.G. Younkin, G.A. Carlson, and C. Iadecola. 2002. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am. J. Physiol. Heart Circ. Physiol. 283:H315-H323. https ://doi.org /10.1152 /ajpheart.00022.2002
125. O'Driscoll, M.C., S.B. Daly, J.E. Urquhart, G.C.M. Black, D.T. Pilz, K. Brockmann, M. McEntagart, G. Abdel-Salam, M. Zaki, N.I. Wolf, et al. 2010. Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria. Am. J. Hum. Genet. 87:354-364. https ://doi.org /10.1016 /j.ajhg.2010.07.012
126. Oakley, H., S.L. Cole, S. Logan, E. Maus, P. Shao, J. Craft, A. Guillozet-Bongaarts, M. Ohno, J. Disterhoft, L. Van Eldik, et al. 2006. Intraneuronal betaamyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26:10129-10140. https ://doi.org /10.1523 /JNE URO SCI.1202-06.2006
127. Ossenkoppele, R., W.M. van der Flier, M.D. Zwan, S.F. Adriaanse, R. Boellaard, A.D. Windhorst, F. Barkhof, A.A. Lammertsma, P. Scheltens, and B.N.M. van Berckel. 2013. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 80:359-365. https ://doi.org /10.1212 /WNL.0b013e31827f0889
128. Pardridge, W.M. 2015. Targeted delivery of protein and gene medicines through the blood-brain barrier. Clin. Pharmacol. Ther. 97:347-361. https ://doi.org /10.1002 /cpt.18
129. Park, J.-C., S.H. Baik, S.-H. Han, H.J. Cho, H. Choi, H.J. Kim, H. Choi, W. Lee, D.K. Kim, and I. Mook-Jung. 2017. Annexin A1 restores Aβ1-42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Aging Cell. 16:149-161. https ://doi.org /10.1111 /acel.12530
130. Park, L., J. Zhou, P. Zhou, R. Pistick, S. El Jamal, L. Younkin, J. Pierce, A. Arreguin, J. Anrather, S.G. Younkin, et al. 2013a. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. USA. 110:3089-3094. https ://doi.org /10.1073 /pnas.1300021110
131. Park, L., P. Zhou, K. Koizumi, S. El Jamal, M.L. Previti, W.E. Van Nostrand, G. Carlson, and C. Iadecola. 2013b. Brain and circulating levels of Aβ1-40 differentially contribute to vasomotor dysfunction in the mouse brain. Stroke. 44:198-204. https ://doi.org /10.1161 /STR OKE AHA.112.670976
132. Paul, J., S. Strickland, and J.P. Melchor. 2007. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J. Exp. Med. 204:1999-2008. https ://doi.org /10.1084 /jem.20070304
133. Poliakova, T., O. Levin, A. Arablinskiy, E. Vasenina, and I. Zerr. 2016. Cerebral microbleeds in early Alzheimer's disease. J. Neurol. 263:1961-1968. https ://doi.org /10.1007 /s00415-016-8220-2
134. Potter, R., B.W. Patterson, D.L. Elbert, V. Ovod, T. Kasten, W. Sigurdson, K. Mawuenyega, T. Blazey, A. Goate, R. Chott, et al. 2013. Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers. Sci. Transl. Med. 5:189ra77. https ://doi.org /10.1126 /scitranslmed.3005615
135. Protas, H.D., K. Chen, J.B.S. Langbaum, A.S. Fleisher, G.E. Alexander, W. Lee, D. Bandy, M.J. de Leon, L. Mosconi, S. Buckley, et al. 2013. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 70:320-325. https ://doi.org /10.1001 /2013.jamaneurol.286
136. Raber, J., D. Wong, M. Buttini, M. Orth, S. Bellosta, R.E. Pitas, R.W. Mahley, and L. Mucke. 1998. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. USA. 95:10914-10919. https ://doi.org /10.1073 /pnas.95.18.10914
137. Reiman, E.M., K. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, D. Osborne, A.M. Saunders, and J. Hardy. 2004. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. USA. 101:284-289. https ://doi.org /10.1073 /pnas.2635903100
138. Rokka, J., T.J. Grönroos, T. Viljanen, O. Solin, and M. Haaparanta-Solin. 2017. HPLC and TLC methods for analysis of [(18)F]FDG and its metabolites from biological samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1048:140-149. https ://doi.org /10.1016 /j.jchromb.2017.01.042
139. Sagare, A.P., R.D. Bell, Z. Zhao, Q. Ma, E.A. Winkler, A. Ramanathan, and B.V. Zlokovic. 2013. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat. Commun. 4:2932. https ://doi.org /10.1038 /ncomms3932
140. Salloway, S., T. Gur, T. Berzin, R. Tavares, B. Zipser, S. Correia, V. Hovanesian, J. Fallon, V. Kuo-Leblanc, D. Glass, et al. 2002. Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. J. Neurol. Sci. 203-204:183-187. https ://doi.org /10.1016 /S0022-510X(02)00288-5
141. Salomon-Zimri, S., A. Boehm-Cagan, O. Liraz, and D.M. Michaelson. 2014. Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice. Neurodegener. Dis. 13:86-92. https ://doi.org /10.1159 /000354777
142. Salomon-Zimri, S., O. Liraz, and D.M. Michaelson. 2015. Behavioral testing affects the phenotypic expression of APOE ε3 and APOE ε4 in targeted replacement mice and reduces the differences between them. Alzheimers Dement (Amst). 1:127-135
143. Sengillo, J.D., E.A. Winkler, C.T. Walker, J.S. Sullivan, M. Johnson, and B.V. Zlokovic. 2013. Deficiency in mural vascular cells coincides with bloodbrain barrier disruption in Alzheimer's disease. Brain Pathol. 23:303-310. https ://doi.org /10.1111 /bpa.12004
144. Shams, S., and L.-O. Wahlund. 2016. Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field. Biomarkers Med. 10:9-18. https ://doi.org /10.2217 /bmm.15.101
145. Shams, S., J. Martola, T. Granberg, X. Li, M. Shams, S.M. Fereshtehnejad, L. Cavallin, P. Aspelin, M. Kristoffersen-Wiberg, and L.O. Wahlund. 2015. Cerebral microbleeds: different prevalence, topography, and risk factors depending on dementia diagnosis-the Karolinska Imaging Dementia Study. AJNR Am. J. Neuroradiol. 36:661-666. https ://doi.org /10.3174 / ajnr.A4176
146. Shaw, M.A., Z. Gao, K.E. McElhinney, S. Thornton, M.J. Flick, A. Lane, J.L. Degen, J.K. Ryu, K. Akassoglou, and E.S. Mullins. 2017. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease. J. Neurosci. 37:3776-3788. https ://doi.org /10.1523 /JNE URO SCI.2932-15.2017
147. Sheline, Y.I., J.C. Morris, A.Z. Snyder, J.L. Price, Z. Yan, G. D'Angelo, C. Liu, S. Dixit, T. Benzinger, A. Fagan, et al. 2010. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42. J. Neurosci. 30:17035-17040. https ://doi.org /10.1523 /JNE URO SCI.3987-10.2010
148. Shibata, M., S. Yamada, S.R. Kumar, M. Calero, J. Bading, B. Frangione, D.M. Holtzman, C.A. Miller, D.K. Strickland, J. Ghiso, and B.V. Zlokovic. 2000. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106:1489-1499. https ://doi.org /10.1172 /JCI10498
149. Smith, A.J., X. Yao, J.A. Dix, B.-J. Jin, and A.S. Verkman. 2017. Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. eLife. 6:e27679. https ://doi.org /10.7554 /eLife.27679
150. Snyder, H.M., R.A. Corriveau, S. Craft, J.E. Faber, S.M. Greenberg, D. Knopman, B.T. Lamb, T.J. Montine, M. Nedergaard, C.B. Schaffer, et al. 2015. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement. 11:710-717. https :// doi.org /10.1016 /j.jalz.2014.10.008
151. Sokoloff, L., M. Reivich, C. Kennedy, M.H. Des Rosiers, C.S. Patlak, K.D. Pettigrew, O. Sakurada, and M. Shinohara. 1977. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:897-916. https ://doi.org /10.1111 /j.1471-4159.1977.tb10649.x
152. Sols, A., and R.K. Crane. 1954. Substrate specificity of brain hexokinase. J. Biol. Chem. 210:581-595
153. Soto, I., L.C. Graham, H.J. Richter, S.N. Simeone, J.E. Radell, W. Grabowska, W.K. Funkhouser, M.C. Howell, and G.R. Howell. 2015. APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction. PLoS Biol. 13:e1002279. https ://doi.org /10.1371 /journal.pbio.1002279
154. Southworth, R., C.R. Parry, H.G. Parkes, R.A. Medina, and P.B. Garlick. 2003. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat. NMR Biomed. 16:494-502. https ://doi.org /10.1002 /nbm.856
155. Spector, R., S. Robert Snodgrass, and C.E. Johanson. 2015. A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans. Exp. Neurol. 273:57-68. https ://doi.org /10.1016 /j.expneurol.2015.07.027
156. Storck, S.E., S. Meister, J. Nahrath, J.N. Meißner, N. Schubert, A. Di Spiezio, S. Baches, R.E. Vandenbroucke, Y. Bouter, I. Prikulis, et al. 2016. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier. J. Clin. Invest. 126:123-136. https ://doi.org /10.1172 /JCI81108
157. Suri, S., C.E. Mackay, M.E. Kelly, M. Germuska, E.M. Tunbridge, G.B. Frisoni, P.M. Matthews, K.P. Ebmeier, D.P. Bulte, and N. Filippini. 2015. Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele. Alzheimers Dement. 11:648-57.e1. https ://doi.org /10.1016 /j.jalz.2014.05.1755
158. Sweeney, M.D., A.P. Sagare, and B.V. Zlokovic. 2015. Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease. J. Cereb. Blood Flow Metab. 35:1055-1068. https :// doi.org /10.1038 /jcbfm.2015.76
159. Sweeney, M.D., S. Ayyadurai, and B.V. Zlokovic. 2016. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat. Neurosci. 19:771-783. https ://doi.org /10.1038 /nn.4288
160. Tanifum, E.A., Z.A. Starosolski, S.W. Fowler, J.L. Jankowsky, and A.V. Annapragada. 2014. Cerebral vascular leak in a mouse model of amyloid neuropathology. J. Cereb. Blood Flow Metab. 34:1646-1654. https ://doi.org /10.1038 /jcbfm.2014.125
161. Tanzi, R.E. 2012. The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2:a006296. https ://doi.org /10.1101 /cshperspect.a006296
162. Tarasoff-Conway, J.M., R.O. Carare, R.S. Osorio, L. Glodzik, T. Butler, E. Fieremans, L. Axel, H. Rusinek, C. Nicholson, B.V. Zlokovic, et al. 2015. Clearance systems in the brain-implications for Alzheimer disease. Nat. Rev. Neurol. 11:457-470. https ://doi.org /10.1038 /nrneurol.2015.119
163. Thambisetty, M., L. Beason-Held, Y. An, M.A. Kraut, and S.M. Resnick. 2010. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch. Neurol. 67:93-98. https ://doi.org /10.1001 /archneurol.2009.913
164. Toledo, J.B., N.J. Cairns, X. Da, K. Chen, D. Carter, A. Fleisher, E. Householder, N. Ayutyanont, A. Roontiva, R.J. Bauer, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI). 2013. Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathol. Commun. 1:65. https ://doi.org /10.1186 /2051-5960-1-65
165. Ujiie, M., D.L. Dickstein, D.A. Carlow, and W.A. Jefferies. 2003. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation. 10:463-470. https ://doi.org /10.1038 /sj.mn.7800212
166. van Assema, D.M.E., M. Lubberink, M. Bauer, W.M. van der Flier, R.C. Schuit, A.D. Windhorst, E.F.I. Comans, N.J. Hoetjes, N. Tolboom, O. Langer, et al. 2012. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain. 135:181-189. https ://doi.org /10.1093 /brain /awr298
167. van de Haar, H.J., S. Burgmans, J.F.A. Jansen, M.J.P. van Osch, M.A. van Buchem, M. Muller, P.A.M. Hofman, F.R.J. Verhey, and W.H. Backes. 2016a. Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. Radiology. 281:527-535. https ://doi.org /10.1148 /radiol.2016152244
168. van de Haar, H.J., J.F.A. Jansen, M.J.P. van Osch, M.A. van Buchem, M. Muller, S.M. Wong, P.A.M. Hofman, S. Burgmans, F.R.J. Verhey, and W.H. Backes. 2016b. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging. Neurobiol. Aging. 45:190-196. https ://doi.org /10.1016 /j.neurobiolaging.2016.06.006
169. van de Haar, H.J., J.F.A. Jansen, C.R.L.P.N. Jeukens, S. Burgmans, M.A. van Buchem, M. Muller, P.A.M. Hofman, F.R.J. Verhey, M.J.P. van Osch, and W.H. Backes. 2017. Subtle blood-brain barrier leakage rate and spatial extent: Considerations for dynamic contrast-enhanced MRI. Med. Phys. 44:4112-4125. https ://doi.org /10.1002 /mp.12328
170. Vanlandewijck, M., T. Lebouvier, M. Andaloussi Mäe, K. Nahar, S. Hornemann, D. Kenkel, S.I. Cunha, J. Lennartsson, A. Boss, C.-H. Heldin, et al. 2015. Functional Characterization of Germline Mutations in PDG FB and PDG FRB in Primary Familial Brain Calcification. PLoS One. 10:e0143407. https ://doi.org /10.1371 /journal.pone.0143407
171. Verghese, P.B., J.M. Castellano, and D.M. Holtzman. 2011. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 10:241-252. https ://doi.org /10.1016 /S1474-4422(10)70325-2
172. Wang, D., P. Kranz-Eble, and D.C. De Vivo. 2000. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum. Mutat. 16:224-231. https ://doi.org /10.1002 /1098-1004(200009)16 :3<224::AID-HUMU5>3.0.CO;2-P
173. Wang, D., S.-P. Li, J.-S. Fu, S. Zhang, L. Bai, and L. Guo. 2016. Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice. J. Neurophysiol. 116:2173-2179. https ://doi.org /10.1152 /jn.00510.2016
174. Wardlaw, J.M., E.E. Smith, G.J. Biessels, C. Cordonnier, F. Fazekas, R. Frayne, R.I. Lindley, J.T. O'Brien, F. Barkhof, O.R. Benavente, et al. STandards for ReportIng Vascular changes on nEuroimaging (STR IVE v1). 2013. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12:822-838. https ://doi.org /10.1016 /S1474-4422(13)70124-8
175. Webster, S.J., A.D. Bachstetter, P.T. Nelson, F.A. Schmitt, and L.J. Van Eldik. 2014. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front. Genet. 5:88. https ://doi.org /10.3389 /fgene.2014.00088
176. Wen, P.H., R. De Gasperi, M.A.G. Sosa, A.B. Rocher, V.L. Friedrich Jr., P.R. Hof, and G.A. Elder. 2005. Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice. Development. 132:3873-3883. https ://doi.org /10.1242 /dev.01946
177. Winkler, E.A., J.D. Sengillo, A.P. Sagare, Z. Zhao, Q. Ma, E. Zuniga, Y. Wang, Z. Zhong, J.S. Sullivan, J.H. Griffin, et al. 2014. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALSmodel mice. Proc. Natl. Acad. Sci. USA. 111:E1035-E1042. https ://doi.org /10.1073 /pnas.1401595111
178. Winkler, E.A., Y. Nishida, A.P. Sagare, S.V. Rege, R.D. Bell, D. Perlmutter, J.D. Sengillo, S. Hillman, P. Kong, A.R. Nelson, et al. 2015. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat. Neurosci. 18:521-530. https ://doi.org /10.1038 /nn.3966
179. Wyss, L., J. Schäfer, S. Liebner, M. Mittelbronn, U. Deutsch, G. Enzmann, R.H. Adams, M. Aurrand-Lions, K.H. Plate, B.A. Imhof, and B. Engelhardt. 2012. Junctional adhesion molecule (JAM)-C deficient C57BL/6 mice develop a severe hydrocephalus. PLoS One. 7:e45619. https ://doi.org /10.1371 /journal.pone.0045619
180. Xie, L., H. Kang, Q. Xu, M.J. Chen, Y. Liao, M. Thiyagarajan, J. O'Donnell, D.J. Christensen, C. Nicholson, J.J. Iliff, et al. 2013. Sleep drives metabolite clearance from the adult brain. Science. 342:373-377. https ://doi.org /10.1126 /science.1241224
181. Yanagida, K., C.H. Liu, G. Faraco, S. Galvani, H.K. Smith, N. Burg, J. Anrather, T. Sanchez, C. Iadecola, and T. Hla. 2017. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc. Natl. Acad. Sci. USA. 114:4531-4536. https ://doi.org /10.1073 /pnas.1618659114
182. Yates, P.A., P.M. Desmond, P.M. Phal, C. Steward, C. Szoeke, O. Salvado, K.A. Ellis, R.N. Martins, C.L. Masters, D. Ames, et al. AIBL Research Group. 2014. Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology. 82:1266-1273. https ://doi.org /10.1212 /WNL.0000000000000285
183. Zeisel, A., A.B. Muñoz-Manchado, S. Codeluppi, P. Lönnerberg, G. La Manno, A. Juréus, S. Marques, H. Munguba, L. He, C. Betsholtz, et al. 2015. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science. 347:1138-1142. https ://doi.org /10.1126 /science.aaa1934
184. Zenaro, E., E. Pietronigro, V. Della Bianca, G. Piacentino, L. Marongiu, S. Budui, E. Turano, B. Rossi, S. Angiari, S. Dusi, et al. 2015. Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21:880-886. https ://doi.org /10.1038 /nm.3913
185. Zhao, Z., and B.V. Zlokovic. 2014. Blood-brain barrier: a dual life of MFSD2A? Neuron. 82:728-730. https ://doi.org /10.1016 /j.neuron.2014.05.012
186. Zhao, Z., A.R. Nelson, C. Betsholtz, and B.V. Zlokovic. 2015a. Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 163:1064-1078. https ://doi.org /10.1016 /j.cell.2015.10.067
187. Zhao, Z., A.P. Sagare, Q. Ma, M.R. Halliday, P. Kong, K. Kisler, E.A. Winkler, A. Ramanathan, T. Kanekiyo, G. Bu, et al. 2015b. Central role for PIC ALM in amyloid-β blood-brain barrier transcytosis and clearance. Nat. Neurosci. 18:978-987. https ://doi.org /10.1038 /nn.4025
188. Zhong, Z., R. Deane, Z. Ali, M. Parisi, Y. Shapovalov, M.K. O'Banion, K. Stojanovic, A. Sagare, S. Boillee, D.W. Cleveland, and B.V. Zlokovic. 2008. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11:420-422. https ://doi.org /10.1038 /nn2073
189. Zhong, Z., H. Ilieva, L. Hallagan, R. Bell, I. Singh, N. Paquette, M. Thiyagarajan, R. Deane, J.A. Fernandez, S. Lane, et al. 2009. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J. Clin. Invest. 119:3437-3449
190. Zipser, B.D., C.E. Johanson, L. Gonzalez, T.M. Berzin, R. Tavares, C.M. Hulette, M.P. Vitek, V. Hovanesian, and E.G. Stopa. 2007. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging. 28:977-986. https ://doi.org /10.1016 /j.neurobiolaging.2006.05.016
191. Zlokovic, B.V. 2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 57:178-201. https ://doi.org /10.1016 /j.neuron.2008.01.003
192. Zlokovic, B.V. 2011. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12:723-738
193. Zlokovic, B.V. 2013. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol. 70:440-444. https ://doi.org /10.1001 /jamaneurol.2013.2152
194. Zlokovic, B.V., and J.H. Griffin. 2011. Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci. 34:198-209. https ://doi.org /10.1016 /j.tins.2011.01.005
195. Zonneveld, H.I., J.D.C. Goos, M.P. Wattjes, N.D. Prins, P. Scheltens, W.M. van der Flier, J.P.A. Kuijer, M. Muller, and F. Barkhof. 2014. Prevalence of cortical superficial siderosis in a memory clinic population. Neurology. 82:698-704. https ://doi.org /10.1212 /WNL.0000000000000150